Trials / Completed
CompletedNCT01197859
Three Month Clinical Evaluation of the Contamac 74% Silicone Hydrogel Contact Lens
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Contamac Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the clinical performance of the contamac silicone hydrogel contact lens with a predicate device (Cooper Vision Biofinity).
Detailed description
The purpose of this study is to evaluate the clinical performance of the Contamac lens in comparison with a currently marketed silicone hydrogel: Biofinity® (CooperVision). This is a 3-month, open-label, bilateral, parallel group, randomised, daily wear study. Approx. two-thirds of the subjects will wear the Contamac Silicone Hydrogel lens in both eyes while the other third will wear control lenses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Definitive Contact Lens | Daily wear contact lens |
| DEVICE | Biofinity | Daily wear contact lens |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2010-09-09
- Last updated
- 2020-08-12
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01197859. Inclusion in this directory is not an endorsement.